Molecular Cytogenetic Analysis of Eight Inversion Duplications of Human Chromosome 13q That Each Contain a Neocentromere  by Warburton, Peter E. et al.
Am. J. Hum. Genet. 66:1794–1806, 2000
1794
Molecular Cytogenetic Analysis of Eight Inversion Duplications of Human
Chromosome 13q That Each Contain a Neocentromere
Peter E. Warburton,1 Marisa Dolled,1 Radma Mahmood,1 Alicia Alonso,1 Shulan Li,1
Kenji Naritomi,3 Takaya Tohma,4 Toshiro Nagai,5 Tomonobu Hasegawa,7 Hirofumi Ohashi,6
Lutgarde C. P. Govaerts,8 Bert H. J. Eussen,8 Jan O. Van Hemel,8 Carmen Lozzio,9
Stuart Schwartz,10 Jennifer J. Dowhanick-Morrissette,11 Nancy B. Spinner,11 Horacio Rivera,12
John A. Crolla,13 Chih-yu Yu,2 and Dorothy Warburton2
1Department of Human Genetics, Mount Sinai School of Medicine, and 2Department of Genetics and Development, Columbia University,
New York; Departments of 3Medical Genetics and 4Pediatrics, University of the Ryukyus School of Medicine, Okinawa, Japan; 5Department
of Pediatrics, Dokkyo University, School of Medicine, Koshigaya Hospital, and 6Division of Medical Genetics, Saitama Children’s Medical
Center, Saitama, Japan; 7Department of Pediatrics, Keio University School of Medicine, Tokyo; 8Department of Clinical Genetics, University
Hospital Dijkzigt, Erasmus University, Rotterdam; 9Developmental and Genetic Center, University of Tennessee Medical Center, Knoxville;
10Department of Genetics, Center for Human Genetics, Case Western Reserve University and University Hospitals of Cleveland, Cleveland;
11Division of Human Genetics and Molecular Biology, Children’s Hospital of Philadelphia, Philadelphia; 12Division de Genetica, Instituto
Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico; and 13Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury,
Wiltshire, United Kingdom
Neocentromeres are fully functional centromeres that have arisen in previously noncentromeric chromosomal lo-
cations on rearranged chromosomes. The formation of neocentromeres results in the mitotic stability of chromo-
somal fragments that do not contain endogenous centromeres and that would normally be lost. Here we describe
a unique collection of eight independent patient-derived cell lines, each of which contains a neocentromere on a
supernumerary inversion duplication of a portion of human chromosome 13q. Findings in these patients reveal
insight into the clinical manifestations associated with polysomy for portions of chromosome 13q. The results of
FISH and immunoﬂuorescent analysis of the neocentromeres in these chromosomes conﬁrm the lack of a-satellite
DNA and the presence of CENtromere proteins (CENP)-C, -E, and hMAD2. The positions of the inversion break-
points in these chromosomes have been placed onto the physical map of chromosome 13, by means of FISH
mapping with cosmid probes. These cell lines deﬁne, within chromosome 13q, at least three distinct locations where
neocentromeres have formed, with ﬁve independent neocentromeres in band 13q32, two in band 13q21, and one
in band 13q31. The results of examination of the set of 40 neocentromere-containing chromosomes that have thus
far been described, including the 8 neocentromere-containing chromosomes from chromosome 13q that are described
in the present study, suggest that chromosome 13q has an increased propensity for neocentromere formation,
relative to some other human chromosomes. These neocentromeres will provide the means for testing hypotheses
about sequence requirements for human centromere formation.
Introduction
The centromere is the chromosomal component respon-
sible for the proper segregation of replicated chromatids
during mitosis and meiosis. A better understanding of
the requirements for centromere formation and function
is required before the promise of artiﬁcial human chro-
mosomes used as autonomous gene-delivery vectors can
be fully realized (Warburton 1999).
Normal human centromeres all contain up to sev-
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eral million base pairs of tandemly repeated a-sat-
ellite DNA. Introduction of a-satellite DNA into hu-
man ﬁbrosarcoma HT1080 cells can result in de novo
centromere formation (Harrington et al. 1997; Ikeno
et al. 1998; Henning et al. 1999). However, the results
of examination of inactive centromeres in dicentric
chromosomes and of neocentromeres demonstrate
that unknown epigenetic modiﬁcations are required
for centromere formation (Warburton et al. 1997).
Stable dicentric chromosomes have an inactive cen-
tromere containing a large array of a-satellite DNA that
does not form a centromere, suggesting a reversibility
of the centromeric epigenetic mark (Sullivan and
Schwartz 1995). Conversely, neocentromeres, which are
found on mitotically stable chromosomes separated
from endogenous centromeres, do not contain a-satel-
lite DNA yet have fully functional centromeres, sug-
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gesting acquisition of the centromeric epigenetic mark
by previously noncentromeric genomic DNA (Choo
1997). Thus, studies of the requirements for human-
centromere formation are no longer done simply to seek
the particular primary sequence that determines centro-
mere formation but, rather, are also done to investigate
the nature of the associated epigenetic modiﬁcations re-
quired for centromere formation. Possible mechanisms
for this epigenetic modiﬁcation include the presence and
propagation of a centromere-speciﬁc nucleosome con-
taining the histone H3–like CENP-A (Warburton et al.
1997), a differential replication timing of centromeric
DNA, or covalent modiﬁcations such as DNA meth-
ylation or histone H4 deacetylation (Murphy and Kar-
pen 1998; Wiens and Sorger 1998).
Neocentromeres provide an opportunity to examine
and compare single- or low-copy centromeric DNA in
the absence of large arrays of repetitive DNA, thereby
permitting further assessment of the role of the primary
DNA sequence in centromere formation. Approxi-
mately 40 neocentromeres have been described on de-
rivatives of 15 different human chromosomes. As a re-
sult of the increasingly routine clinical application of
FISH with chromosome-speciﬁc a-satellite DNA probes
to identify the origin of marker chromosomes, anal-
phoid neocentromeres are identiﬁed and are reported at
an increasing rate.
The ﬁrst neocentromere to be molecularly character-
ized—one that was derived from a pericentric deletion
of chromosome 10 and that was found in human chro-
mosome 10q25—was shown to have sequence-tagged
site (STS) and restriction maps that were identical to
those of the corresponding regions in normal chromo-
somes 10 (Voullaire et al. 1993; du Sart et al. 1997).
Remarkably, the DNA sequence of the underlying 80
kb of neocentromeric DNA (ncDNA) had few, if any,
sequence characteristics that would suggest a reason for
its centromere formation (Barry et al. 1999). However,
given that there were few a priori expectations for what
these centromeric sequence characteristics might be, it
may not be surprising that the characteristics were not
apparent from this ﬁrst example. Additional examples
of ncDNA will be critical for sequence comparisons, to
identify and to evaluate conserved primary or secondary
sequence characteristics that may be important for cen-
tromere formation (Koch 2000).
In the present report, we will describe the initial mo-
lecular cytogenetic analysis of a novel collection of eight
independent neocentromeres that have all formed in
chromosome 13q. The patients in whom these chro-
mosomes were identiﬁed have permitted us to evaluate
the clinical features associated with chromosomally
pure partial tetrasomy or trisomy 13q without aneu-
ploidy for any other chromosomes. According to the
results of FISH and immunoﬂuorescence analysis, these
13q neocentromeres are all negative for a-satellite
DNA, but they are positive for kinetochore proteins.
FISH analysis of the inversion breakpoints, done with
physically mapped ordered cosmids from chromosome
13q used as FISH probes, has permitted delineation of
the relative sizes of these chromosomes and placement
of the breakpoints onto the physical map of chromo-
some 13 (Cayanis et al. 1998). At least three distinct
locations within chromosome 13q have formed neo-
centromeres, with multiple independent examples in
bands 13q32 and 13q21. Of the total of 40 human
neocentromeres that have thus far been described, 8
occur in chromosome 13q, suggesting nonrandom chro-
mosome involvement. This might indicate either selec-
tion for fetal survival or differences in the propensity
for neocentromere formation in different parts of the
genome. The implications of this unique set of neocen-
tromeres in the analysis of the requirements for human
centromere formation are discussed.
Material and Methods
Patient Ascertainment
Patients with chromosome 13q neocentromeres were
identiﬁed through a survey of the literature, including
meeting abstracts, and authors were invited to submit
Epstein-Barr virus–transformed lymphoblast or ﬁbro-
blast cell lines for further analysis. All patients were orig-
inally ascertained as a result of developmental delay and
congenital malformations, and diagnosis was made cy-
togenetically by means of G-banding, spectral kary-
otyping (SKY) FISH (Huang et al. 1998), whole-chro-
mosome painting probes, and/or comparative genomic
hybridization (CGH) (du Manoir et al. 1993). Detailed
clinical features were noted for each patient (table 1).
The overall spectrum of affected systems was identiﬁed.
To ensure completeness, speciﬁc follow-up inquiries
were made with regard to each system not mentioned
in the original report.
Molecular Cytogenetic Analysis
FISH and immunoﬂuorescence were performed essen-
tially as described elsewhere (Alonso et al., in press).
FISH done with commercially available probes—for ex-
ample, with WCP 13, CEP 13/21, LSI 13 RB1, and LSI
13 (all from Vysis), and an “all-centromere” probe (On-
cor)—was performed according to the manufacturers’
directions. Cosmids from chromosome 13qwere derived
from the chromosome 13 physical map available from
The Human Genome Project at Columbia University
(Cayanis et al. 1998). An additional chromosome
13–speciﬁc painting probe was prepared by means of
Alu PCR of DNA from a rodent human somatic-cell
hybrid containing chromosome 13 as its only human
Table 1
Clinical Features of Patients with Partial Trisomy or Tetrasomy 13q
TRISOMY 13q14-qter,
Patient 13a
TRISOMY 13q21-qter,
Patient 13b
TETRASOMY 13q21-qter
TETRASOMY 13q31-
qter, Patient 13e
TETRASOMY 13q32-qter
Patient 13c Patient 13d Patient 13f Patient 13g Patient 13h
Agea 17 mo 10 mo 8 years Died at 13 d 4 years Died at 3 years Died at 10 years 11 years
Growth Normal birth weight Low birth weight Normal AGA at 7 mo Normal Normal birth weight Normal birth weight; normal
growth at 5 years and be-
low normal growth at 8
years
Normal birth weight; normal growth at 7
years, obese
Head Left plagiocephaly Brachycephaly and
microcephaly
Normal Normal CT scan Normal Microcephaly and
scaphocephaly
Normocephalic; normal CT
scan at birth
Normal
Facies Flat philtrum Thick eyebrows and
curly eyelashes
Submucosal cleft pal-
ate and high nasal
bridge
Hypertelorism and
left cleft lip/
gum
Thick eyebrows and
hypertelorism
Bulbous nose, short neck,
and high-arched palate
Biﬁd nose, anteverted nostrils,
and hypertelorism
Bulbous nose, biﬁd tip, anteverted
nostrils, high-arched palate, and
epicanthus
Eyes Bil. glaucoma, nystagmus,
and bil. retinoblastoma
Bil. microphthalmia Strabismus Normal Strabismus Agenesis in the right eye
and left microphthalmia
Iris and choroidal
colobomata
Right microphthalmia, coloboma,
and tumor of the right optic nerve
Ears Right total deafness and left
conductive diseases
Normal Conductive deafness
and earlobe
anomaly
Low set and pos-
teriorly rotated
Deformed lobes Low set and posteriorly
rotated, with right hearing
loss
Low set Right low set, posteriorly rotated, right
preauriculoar pit, and right hearing loss
CNS Hypertonicity and abnormal
brain density on CT
Developmental delay Mild mental
retardation
Hypotonia Mild mental retarda-
tion and seizures
Profound mental retarda-
tion and agenesis of
corpus callosum
Intractable seizures, loss of
function, and hypotonia;
MRI at age 10 years shows
swollen gray matter
Intractable seizures, moderate mental retar-
dation, early hypotonia, later ataxia, and
hemiparesis
Skin/teeth Hemangioma of the arm
and facial vitiligo
Normal Patchy pigmentation,
multiple caries,
and left accessory
nipple
Normal Excess teeth (three in
lower jaw)
Hemangioma of the arm,
head, and neck; scalp
lesion
Hemangioma of the head
and back
Hemangioma of the head and neck; poorly
implanted and delayed teeth
Heart/lung Normal Normal Normal ASD, VSD, PDA,
and pulmonary
hypoplasia
PDA, diaphragmatic
hernia, and bron-
chial anomalies
PDA, ventricular outﬂow
obstruction, and su-
baortic stenosis
Normal PDA at birth but now normal
Gastrointestinal Normal Normal Normal Normal Intestinal malrotation Normal Normal Normal
Extremities Normal Bil. postaxial
polydactyly
Right camptodactyly
and toe hypoplasia
Left postaxial
polydactyly
Normal Normal Tapering ﬁngers Small hands and feet, clinodactyly of the
hands, and syndactyly 2/3 of feet
Skeletal Normal Normal Normal 11 ribs and
hemivertebrae
Scoliosis 11 ribs Normal Right hemiatrophy, asymmetrical chest, and
wide-spaced nipples
Urogenital Hypospadius, cryptorchidism,
and normal renal USG
Normal female Normal female Normal male and
left renal agenesis
Hypospadius and
hydronephrosis
Normal female Normal male Subseptated uterus, lower septated vaginal
canal, and duplicated left ureter
NOTE.—AGA = average for gestational age; ASD = atrial septal defect; MRI = magnetic-resonance imaging; PDA = patent ductus arteriosus; USG = ultrasonogram; VSD = ventricular septal defect; bil. = bilateral.
a At last examination.
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complement (Liu et al. 1993). DNA used for FISH
probes was labeled with either biotin or digoxygenin and
was detected with either ﬂuor-conjugated streptavidin or
antidigoxygenin, by use of standard protocols.
Immunoﬂuorescence with antibodies to CENP-C was
performed on 3:1 methanol:acetic acid–ﬁxed chromo-
somes. Immunoﬂuorescence with antibodies to CENP-
A, CENP-E, and hMAD2 was performed on aqueous
cytospin preparations. Rabbit anti–CENP-C and rabbit
anti-hMAD2 were detected with the use of goat anti-
rabbit immunoglobulin G. Chromosomes were coun-
terstained with 4,6 diamidino-2-phenylindole (DAPI)
(blue). Photomicrographs were obtained on a Nikon
Eclipse 800 ﬂuorescent/phase microscope equipped with
a Sony DKC 5000 camera; each image was collected
separately, by use of single-pass ﬁlter sets (Chroma) and
by merging of separate color channels with the use of
Adobe Photoshop.
Results
Molecular Cytogenetic Analysis of Neocentromere-
Containing Inversion Duplication 13q Chromosomes
In each patient presented here, the results of karyotype
analysis revealed the presence of a supernumerary chro-
mosome, the origins of which were identiﬁed by use of
FISH with chromosome-speciﬁc painting probes, mul-
ticolor SKY FISH, or CGH. The chromosome 13 origin
was conﬁrmed by use of chromosome 13–speciﬁcwhole-
chromosome paint. G-banding conﬁrmed the symmet-
rical inversion duplication and localized the breakpoint
for each chromosome. Each chromosome contained a
primary constriction that was localized to a speciﬁc G-
band. However, the results of FISH done with the use
of an a-satellite DNA probe speciﬁc for both chromo-
some 13 and chromosome 21, as well as an “all-cen-
tromere” probe, showed no signal on these chromo-
somes, thereby conﬁrming the presence of an analphoid
neocentromere. Representative examples of the cell lines
of patients 13b and 13a are shown in ﬁgure 1A and
ﬁgure 1B, respectively.
To conﬁrm formation of a kinetochore at these neo-
centromeres, immunoﬂuorescence was performed, for
each cell line, with antibodies to proteins found to be
associated with active kinetochores—for example,
CENP-C and/or CENP-E. Figure 1C provides a repre-
sentative example of this immunoﬂuorescent analysis,
showing the presence of CENP-C at the neocentromere,
as well as all other centromeres, in the cell line from
patient 13g. In a further investigation of the functional
spectrum of neocentromeres, immunoﬂuorescence
showed that hMAD2, a component of the spindle-as-
sembly checkpoint (Li and Benezra 1996), is also present
at all neocentromeres examined in colcemid-treated
cells, as is shown (see ﬁgure 1D) for the cell line of
patient 13e.
Ideograms of the abnormal chromosomes in these pa-
tients are shown in ﬁgure 2A; they reveal the cytoge-
netically determined positions of the neocentromere and
the inversion breakpoints, relative to normal chromo-
some 13. Six (13c–h) of the eight patients (ﬁg. 2A; table
2) have 23 normal chromosome pairs, including two
normal chromosomes 13, plus the inversion duplication
of chromosome 13q, resulting in partial tetrasomy for
the duplicated portion of chromosome 13q. The re-
maining two patients—patients 13a and 13b (ﬁgure 2A;
table 2)—have one normal chromosome 13, an inversion
duplication chromosome, and a complementary deletion
of one of the normal chromosomes 13, resulting in par-
tial trisomy for the duplicated/deleted region.
No patient had a chromosomal duplication for the
most-proximal region of chromosome 13q (q11.2-q13).
Patient 13a had trisomy for a region extending from
q14-qter, distal to the retinoblastoma gene, plus an ap-
parently complementary ring chromosome containing
q14-pter (Dowhanick et al. 1998). Patients 13c and 13d
had tetrasomy for q21-qter, whereas patient 13b had a
complementary terminal-deletion chromosome that con-
tained 13pter-13q21 and that resulted in trisomy for
q21-qter. Patient 13e had tetrasomy for q31-qter, and
patients 13f–13h had tetrasomy for q32-qter. Figure 2A
also shows the cytogenetic position of a panel of four
ordered cosmids from chromosome 13q that were used
as FISH probes to conﬁrm the morphology of these chro-
mosomes and that were used as reference cosmids for
further analysis in this report.
Clinical Findings in Patients with Partial Trisomy or
Tetrasomy of Chromosome 13q
Each of these patients has tetrasomy or trisomy for
discrete segments of chromosome 13q uncomplicated by
aneusomy for other chromosomal segments. This pro-
vides a unique opportunity to deﬁne the clinical features
associated with duplication for particular regions of
chromosome 13q (table 1). The features of trisomy 13
that were most frequently seen in these patients were
microphthalmia or other major eye defects (ﬁve of eight
patients), hemangiomata (four of eight patients), and
deafness (four of eight patients). All of these defects were
found in patients with the smallest duplications, indi-
cating that distal duplication is sufﬁcient for develop-
ment of these anomalies. Patients 13g and 13h, who had
the most-distal tetrasomy (q32-qter), showed a similar
developmental pattern of early seizures that ﬁrst re-
sponded to medication and then became intractable,
with subsequent severe neurological deterioration oc-
curring (Lozzio et al. 1997; Govaerts et al. 1999). Poly-
dactyly and cleft lip or palate, which are features seen
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Figure 1 FISH and immunoﬂuorescent analysis of neocentromeres. A, FISH analysis of the cell line of patient 13b. Whole-chromosome
13 paint (Wcp 13, red) hybridized to the inversion duplication 13(q21-qter) chromosome (white arrow) as well as to the normal chromosome
13 (white arrowhead) and the deleted 13 (pter-q21) (unwhitened arrowhead). Chromosome 13 and chromosome 21–speciﬁc a-satellite DNA
(green) did not hybridize to the inversion duplication chromosome 13 (middle inset panel), but it did hybridize to the centromeres of the normal
chromosome 13 (left inset panel), the deleted 13 (right inset panel), and the two normal chromosomes 21. B, FISH analysis of the cell line in
patient 13a. Wcp13 (red) hybridized to the inversion duplication 13(q14-qter) (white arrow) as well as to the normal chromosome 13 (white
arrowhead) and the ring 13 (pter-q14) (unwhitened arrowhead). An “all centromere” probe (green) did not hybridize to the inversion duplication
13 (center inset panel), but it did hybridize to all normal centromeres, including the normal 13 (left inset panel) and ring 13 (right inset panel).
Insets show enlarged chromosomes from the same metaphase spread seen in the main ﬁgure, which was rotated, when necessary, with the
wcp13 signal (red) removed for clarity. C, Combined FISH and immunoﬂuorescent analysis of the cell line of patient 13g. Wcp13 (red) hybridizes
to the inversion duplication 13(q32-qter) (white arrow) and to the two normal chromosomes 13 (unwhitened arrowheads). CENP-C (green)
was seen at the neocentromere on the inversion duplication 13 as well as at all normal centromeres. D, Combined FISH and immunoﬂuorescence
analysis of the cell line from patient 13e. Wcp13 (red) hybridizes to the inversion duplication 13(q31-qter) (white arrow) as well as to the two
normal chromosomes 13 (unwhitened arrowheads). hMAD2 (green) is seen at the neocentromere on the inversion duplication 13 as well as at
all normal centromeres. In some cases, Wcp13 faintly detects the short arm of additional acrocentric chromosomes. A–C, 3:1::methanol:acetic
acid–ﬁxed chromosome spread; D, aqueous cytospin chromosome spread.
in 150% of patients with full trisomy 13 (Chu et al.
1994), were each found in only two of the patients with
the most-extensive duplications (table 1). With the ex-
ception of holoprosencephaly, all of the major features
of trisomy 13 were found in at least two of the eight
patients. Thus, trisomy for the proximal bands 13q11-
13q13 does not appear to be necessary for the devel-
opment of most of the more-common features of trisomy
13 (e.g., facial clefting, polydactyly, seizures, eye anom-
alies, deafness, hemangioma, and heart defects). How-
ever, it is striking that none of the eight patients had
holoprosencephaly or other midbrain anomalies, which
are hallmarks of full trisomy 13. This feature may thus
be associated with duplication of the most-proximal re-
gion of the chromosome. Notably, gene expression may
be inactivated in the vicinity of the neocentromere on
these chromosomes, potentially inﬂuencing the clinical
features observed.
FISH Mapping of Inversion Breakpoints
These inversion duplication chromosomes have been
characterized by means of FISH mapping, to further lo-
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Figure 2 Characterization of inversion duplication distal 13q neocentromere chromosomes. A, Ideograms of all abnormal derivative
chromosomes 13 found in the cell lines are shown in a comparison with a normal chromosome 13 (left). The cytogenetically determined position
of the neocentromere and the inversion breakpoint is shown for each chromosome. The cell lines of patients 13a and 13b both contain deletion
chromosomes that are complementary to the inversion duplication chromosomes, resulting in trisomy for the duplicated region. Cell lines from
patients 13c – 13h each have two normal chromosomes 13 and, thus, are tetrasomic for the duplicated region. Reference cosmids used as FISH
probes on cell lines are indicated; a plus sign () indicates that such cosmids are present on chromosomes, whereas a minus sign () indicates
that they are absent from the chromosome. The relative order of 13q32 neocentromeres and cosmid 149D8 is not implied. The relative order
of the 13q21 neocentromeres and cosmid 163E4 is not implied. B, FISH mapping of the 13q14 and 13q21 breakpoints. C, FISH mapping of
the 13q31 and 13q32 breakpoints. The cosmid used as the FISH probe as well as the corresponding STSs and YAC are indicated. Contiguous
YACs are indicated when applicable. Note the inclusion of cosmids, shown in panel A, for reference in panels B and C. Breakpoints have been
placed onto the existing physical map of ordered cosmids and YACs from chromosome 13 (Cayanis et al. 1998).
calize the positions of the breakpoints and to permit
determination of the relative sizes of the chromosomes.
The breakpoint in the cell line of patient 13a is located
in chromosome band q14, which can be distinguished
cytogenetically as the most proximal of all the cell lines
examined (see ﬁg. 2A). The breakpoints in the cell lines
of patients 13b–13d all occur in chromosome band
13q21 and thus require higher-resolution FISHmapping
for determination of their relative sizes. In patient 13e,
the breakpoint in the cell line can be distinguished cy-
togenetically in chromosome band 13q31. In patients
13f–13h, the breakpoints in the cell lines all occur in
band 13q32 and require higher-resolution FISH map-
ping. FISH done with a panel of ordered cosmids from
chromosome 13q (Cayanis et al. 1998) has been used
to determine the position of the inversion breakpoints,
where probes absent from the inversion duplication
chromosome are proximal to the breakpoint and where
probes present on the inversion duplication chromosome
are distal to the breakpoint, relative to positions in a
normal chromosome 13. Chromosome 13–speciﬁc
painting probes were used to identify all normal and
derivative chromosomes 13 in the cells, which acted as
hybridization controls.
Figure 2B and C shows the placement of the break-
points on the published physical map of chromosome
13 (Cayanis et al. 1998); the presence or absence of the
cosmid on the inversion duplication chromosome in each
cell line as well as the corresponding STSs and yeast-
artiﬁcial chromosomes (YACs) are indicated. For clarity,
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Table 2
Chromosomal Rearrangements with Neocentromeres
Chromosome Chromosomal Abnormalitiesa Rearrangement Complementb (%) Mosaicismc Reference
1 Del (pterrp36.1::p32rqter),ring (p32rneorp36.1) Paracentric deletion Balanced 100 (ﬁb), 97 (lym) Slater et al. (1999)
2 Del (pterrp21::p11rqter ), der (p11rneorp21) Paracentric deletion Balanced 100 (ﬁb) Petit and Fryns (1997)
3a Del (pterrneorp23::q25rqter),ring (p23rq25) Paracentric deletion Balanced 100 (ﬁb), 100 (lym) Maraschio et al. (1996)
3b Der (p11rq11), del (pterrp11::q11rq26neorqter) Paracentric deletion Balancedd 100 (ﬁb), 100 (lym) Wandall et al. (1998)
3c Invdup (qterr3q27.2::3q27.2rneorqter) Inversion duplication Tetrasomy q27.2rqter Mosaic Teshima et al. (1998)e
3d Invdup (qterr3q27.2::3q27.2rneorqter) Inversion duplication Tetrasomy q27.2rqter Mosaic Teshima et al. (1998)e
3e Invdup (qterr3q27.1::3q27.1rneorqter) Inversion duplication Tetrasomy q27.1rqter 30 (lym), 6 (ﬁb) Portnoi et al. (1999)
3f Invdup (qterr3q26.2::3q26.2rneorqter) Inversion duplication Tetrasomy q26.2rqter 57 (ﬁb) Cockwell et al., in press
4 Ring (q21rq21neo), del (pter rq21::q21rqter) Paracentric deletion Balanced 75 (ﬁb) Grimbacher et al. (1999)
8a Invdup (pterrp23.1::p23.1rneorpter) Inversion duplication Tetrasomy pterrp23 100 (lym) Ohashi et al. (1994)
8b Invdup (qterrq23::q23rneorqter) Inversion duplication Tetrasomy qter-q23 75 (lym) Sulcova et al. (1999)e
9a Del (p12rqter), invdup (pterrp12::p12rp23neorpter) Inversion duplication Trisomy pterrp12 100 (lym) Vance et al. (1997)
9b Invdup (pterrp21.2::p21.2rp23neorpter) Inversion duplication Tetrasomy pterrp21.2 100 (lym) Depinet et al. (1997)
10a Del (pterrp11.2::q23.2rq25.2neorqter),r(p11.2rq23.2) Paracentric deletion Balanced 100 (ﬁb), 100 (lym) Voullaire et al. (1993)
10b Invdup (qterrq11.2::q11.2rneorqter) Inversion duplication Tetrasomy qterrq11.2 90 (lym) Abeliovich et al. (1996)
10c Del (pter-q11::q23rqter),ring (q11rneorq23) Paracentric deletion Balanced 80 (ﬁb), 62 (lym) Depinet et al. (1997)
11 Del (pterrq22), invdup (qterrq22::q22rneorqter) Inversion duplication Trisomy qterrq22 100 (ﬁb),100 (lym) Depinet et al. (1997)
13a Ring (pterrq14), invdup (qterrq14::q14rq21neorqter) Inversion duplication Trisomy q14-qter 100 (lym) Dowhanick et al. (1998)e
13b Del (pterrq21), invdup (qterrq21::q21rq32neorqter) Inversion duplication Trisomy q21-qter 100 (lym) Rivera et al. (1999)
13c Invdup (qterrq21::q21neorqter) Inversion duplication Tetrasomy q21-qter 49 (lym) Tohma et al. (1998)e
13d Invdup (qterrq21::q21rq32neorqter) Inversion duplication Tetrasomy q21-qter 88 (ﬁb) Warburton et al. (1997)
13e Invdup (qterrq31::q31neorqter) Inversion duplication Tetrasomy q31-qter 60 (lym) Tohma et al. (1998)e
13f Invdup (qterrq32::q32neorqter) Inversion duplication Tetrasomy q32-qter 98 (lym), 8 (ﬁb) Depinet et al. (1997)
13g Invdup (qterrq32::q32neorqter) Inversion duplication Tetrasomy q32-qter 100 (lym), 100 (ﬁb) Govaerts et al. (1999)e
13h Invdup (qterrq32::q32neorqter) Inversion duplication Tetrasomy q32-qter 74 (lym), 25 (ﬁb)f Lozzio et al. (1997)e
14 Del (pterrq32.1), invdup (qterrq32.1::q32.1rneorqter) Inversion duplication Trisomy q32-qter 100 (lym) Sacchi et al. (1996)
15a Invdup (qterrq23::q23neorqter) Inversion duplication Tetrasomy q23-qter 70 (lym) Blennow et al. (1994)
15b Invdup (qterrq24::q24neorqter) Inversion duplication Tetrasomy q24-qter 80 (lym) Blennow et al. (1994)
15c Invdup (qterrq25.3::q25.3rneorqter) Inversion duplication Tetrasomy q25.3-qter 82 (lym) Depinet et al. (1997)
15d Invdup (qterrq25.3::q25.3rneorqter) Inversion duplication Tetrasomy q25.3-qter 74 (lym) Depinet et al. (1997)
15e Invdup (qterrq26.1::q26.1rneorqter) Inversion duplication Tetrasomy q26.1-qter 86 (lym) Depinet et al. (1997)
15f Invdup (qterrq25::q25rneorqter) Inversion duplication Tetrasomy q25-qter 100 (lym) Huang et al. (1998)
15g Invdup (qterrq25::q25rneorqter) Inversion duplication Tetrasomy q25-qter 79 (lym) van den Enden et al. (1996)
17 Del (pterrq22:q23rqter), invdup (q22rq23::q23neorq22) Inversion duplicationg Trisomy q22rq23 100 (lym) Ravnan et al. (1999)e
20 Del (qterrp11.2), invdup (pterrp11.2::p11.2rp21neorpter) Inversion duplication Trisomy p11.2-pter 100 (ﬁb), 100 (lym) Voullaire et al. (1999)
X Rec (qterrq12neorq13.1 or q11.2::q23 or q24rqter) Inversion duplicationh X, deletion X 82 (lym) Kaiser-Rogers et al. (1995)e
Ya Morphologically normal Y, inactive cen  q12neo None Normal 5 (lym) Bukvic et al. (1996)
Yb Inverted Y, inactive cen  neo Inversion Recombinant Y Unstable Rivera et al. (1996)
Yc Morphologically normal Y, inactive cen  q12neo None Normal 94 (lym) Tyler-Smith et al. (1999)
Yd Inversion Y (qterrq11.2::q11.2neorqter) Inversion duplication Deletion Y 70 (ﬁb) Warburton et al. (1997)
a All deletions and rearrangements are written inclusive of the chromosomal material present. Del = deletion; Invdup = inversion duplication.
b Chromosome complement is approximated cytogenetically and considers possible microdeletions or insertions.
c Mosaicism for neocentromere-containing chromosome. The percentage of mosaicism for ﬁbroblasts (ﬁb) and lymphcytes (lym) is given when ascertained. Mosaic (cell lines 3c and 3d) =
patient reported as mosaic, but percentage of mosaicism and cell type are not given.
d Father balanced; dysmorphic proband mosaic (90% ﬁb, 70% lym) for centric fragment der (p11rq11).
e American Society of Human Genetics Annual Meeting abstract.
f An additional 15% had two markers per cell, and 11% of cells had no markers analyzed on lymphocytes at birth.
g Complex rearrangement with both paracentric deletion and inversion duplication of neocentric deleted fragment.
h Asymmetrical inversion duplication.
the reference cosmids used to characterize the chromo-
somes (see ﬁg. 2A) are included in this analysis. Figure
2B shows mapping proximal to cosmid 163E4 in chro-
mosome band q21, and ﬁgure 2C shows mapping prox-
imal to cosmid 149D8 and distal to cosmid 91G11. This
FISH mapping has permitted the ordering of the chro-
mosomes by size (see ﬁg. 2A), with chromosomes pre-
sented from largest to smallest, from left to right. It
would be possible to further molecularly characterize
each breakpoint to high resolution, by means of addi-
tional cosmid and YAC mapping, if it were determined
to be of interest for neocentromere characterization.
Three Distinct Neocentromere Locations in
Chromosome 13q
The results of cytogenetic analysis showed at least
three distinct neocentromere locations within chromo-
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some 13q, with ﬁve independent neocentromeres in band
13q32, two in band 13q21, and one in band 13q31 (ﬁg.
2A). Simultaneous FISH with selected reference cosmids
(ﬁg. 2A) and immunoﬂuorescence with CENP-C have
been used for molecular cytogenetic characterization of
these different neocentromere positions in the cell lines
of patients 13a, 13d, and 13e (ﬁg. 3). In patient 13a,
ﬁndings from FISH analysis of the cell line with cosmid
61G7 located in 13q21.3/13q22 shows hybridization to
either side of the inversion breakpoint. Simultaneous
CENP-C immunoﬂuorescence showed the neocentrom-
ere to be between these FISH signals, consistent with its
cytogenetic localization to the more-proximal chromo-
some band 13q21. In patient 13d, the results of FISH
analysis of the cell line with cosmid 91G11 located in
13q31 again shows hybridization to either side of the
inversion breakpoint. In this patient, however, CENP-C
immunoﬂuorescence showed the neocentromere to be
distal to both FISH signals near one end of the mirror-
image chromosome, consistent with its cytogenetic lo-
calization in chromosome band 13q32. Finally, in pa-
tient 13e, the results both of FISH analysis of the cell
line with cosmid 149D8 located in 13q32 and of CENP-
C immunoﬂuorescence showed the neocentromere to be
near the inversion breakpoint between the FISH signals,
consistent with its localization to chromosome band
13q31. The positions of the neocentromeres have not
been localized within chromosome subbands (e.g., the
relative positions of the 13q32 neocentromeres and cos-
mid 149D8 and of the 13q21 neocentromeres and cos-
mid 163E4 have not been determined by simultaneous
immunoﬂuorescence and FISH (see ﬁg. 2A).
Survey of Reported Neocentromeres
The presence of a neocentromere results in the mitotic
rescue of what would have been acentric unstable chro-
mosomes that would normally have been lost. Forty neo-
centromeres, including the eight 13q neocentromeres
presented here (table 2), have been described in deriv-
atives of 15 human chromosomes. Seven examples have
been seen on chromosomes where neocentromere for-
mation has permitted recovery of both complementary
products of an interstitial deletion event. Of these seven
examples, three—3a, 3b, and 10a (table 2)—resulted
from neocentromere formation on a fusion chromosome
consisting of two acentric terminal fragments, with re-
covery of the complementary pericentric deletion frag-
ment. The other four examples—1, 2, 4, and 10c (table
2)—resulted from neocentromere formation on a para-
centric deletion fragment, with recovery of the comple-
mentary fusion of the centric and acentric terminal frag-
ments. In both of these types of rearrangements, the
resulting karyotype appears to be balanced, resulting in
minimal loss of genetic material and a relatively mild
phenotype that can be exacerbated by mosaicism for
either derivative chromosome (Wandall et al. 1998).
Twenty-eight cases of neocentromere formation, in-
cluding each of the chromosome 13q neocentromeres
presented here (table 2), have permitted recovery of su-
pernumerary inversion duplications of distal chromo-
somal regions (Rivera et al. 1999). In 21 cases, the
karyotype is normal except for the supernumerary chro-
mosome, giving rise to partial tetrasomy for the dupli-
cated portion. In seven cases, a complementary terminal
deletion results in a partial trisomy for the duplicated
region. In general, only cases with duplication of a rel-
atively small distal subfragment were seen, with the no-
table exception of a somatic mutation resulting in in-
version duplication of chromosome 10qter-q11.2, as
seen in leukemic bone marrow (Abeliovich et al. 1996).
A chromosome 17–derived neocentromere resulted from
a paracentric deletion and inversion duplication of the
deleted region, giving rise to an inversion duplication
17q22-q23::q23-q22 neocentromere-containing chro-
mosome (Ravnan et al. 1999).
Neocentromere formation on the sex chromosomes
appears to involve unusual chromosomal rearrange-
ments, compared with neocentromere formation on the
autosomal neocentromeres. The single reported example
of an X chromosome neocentromere is seen on an asym-
metrical inversion duplication fragment (Kaiser-Rogers
et al. 1995). Four neocentromeres have been described
on derivative Y chromosomes. Whereas Yd (table 2) is
an inversion duplication where the endogenous Y cen-
tromere has been deleted, the other three Y-chromosome
derivatives all contain both an inactivated endogenous
Y centromere and a neocentromere in the heterochro-
matic long arm.
The results of examination of the 40 neocentromeres
reported to date reveal that some chromosomal regions
have a higher-than-expected proportion of observed neo-
centromeres; these regions include chromosome 13q
( ), which includes 13q32 ( ), as well as distaln = 8 n = 5
chromosome 15q ( ) and distal chromosome 3qn = 7
( ) (table 2). These high proportions of neocentrom-n = 5
ere formation might be attributed to the compatibility
of fetal survival for trisomies of these chromosomal
regions. However, neocentromeres have thus far not
been observed on derivatives of chromosomes 18 or 21,
despite a high tolerance of trisomies for these chromo-
somes. The combined length (mean percent of the hap-
loid genome) for chromosome 18 (2.93%) and chro-
mosome 21 (1.9%) is 4.83%, which is longer than the
length of chromosome 13 (3.74%). Thus, observation
of 8/40 chromosome 13q–derived neocentromeres and
of 0/40 chromosome 18– or chromosome 21–derived
neocentromeres permits rejection of the hypothesis that
there is an equal propensity, per unit of genome length,
for neocentromere formation on chromosomes 13, 18,
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Figure 3 Molecular cytogenetic analysis of neocentromere position. For each panel, a normal chromosome 13 (left) and the inversion
duplication 13 chromosome (right) from the same metaphase spread are shown. The results of FISH done with the use of reference cosmid
probes from chromosome 13q (green; see ﬁg. 2A) and of immunoﬂuorescence done with the use of antibodies to CENP-C (red) are shown. A,
Patient 13a’s cell line, hybridized with cosmid 61G7 from chromosome band 13q21.3. B, Patient 13d’s cell line, hybridized with cosmid 91G11
from chromosome band 13q31. C, Patient 13e’s cell line, hybridized with cosmid 149D8 from chromosome band 13q32.
and 21 ( ; Fisher exact test). Similar statisticalP ! .001
arguments can be made with use of the observed fre-
quency of neocentromeres observed on the X chromo-
some ( ), which is easily tolerated in multiple in-n = 1
active copies. Similar observations would result if
chromosomes 18, 21, and X had a disproportionately
lower propensity for neocentromere formation. Thus,
the existing set of described neocentromeres provides
statistical support for the idea that the propensity for
neocentromere formation can vary in different chro-
mosomal regions.
Discussion
We have obtained and have performed molecular cy-
togenetic characterization of eight independent inversion
duplication 13q chromosomes with neocentromeres.
These 13q neocentromeres do not contain a-satellite
DNA that can be detected by FISH (ﬁg. 1A and B), and
they are forming centromeres in previously noncentrom-
eric chromosomal locations. Thus, neocentromeres pro-
vide an opportunity to examine the requirements for
human centromere formation in the absence of the large
amounts of tandemly repeated DNA found at normal
centromeres.
Neocentromeres have thus far been shown to contain
all active kinetochore proteins examined, including con-
stitutive structural proteins—for example, CENP-A and
CENP-C (Depinet et al. 1997; Warburton et al. 1997)
(ﬁg. 1C)—and microtubule-binding proteins—for ex-
ample, CENP-E. We have also conﬁrmed the presence
of the spindle-assembly checkpoint protein hMAD2 (ﬁg.
1D) (Li and Benezra 1996) suggesting that neocentrom-
eres are competent to activate this checkpoint. The re-
sults of a recent study have shown identical distribution
patterns for 120 kinetochore proteins in normal cen-
tromeres and two other neocentromeres (examples 10a
and 20; see table 2) (Saffery et al. 2000). As new ki-
netochore proteins—for example, CENP-G (He et al.
1998) and CENP-H (Sugata et al. 1999)—are identiﬁed,
it will be important to test for their presence at neo-
centromeres as well as at inactive centromeres in dicen-
trics, to assess the centromere activity of the proteins
and to ﬁnd any differences between neocentromeres and
normal centromeres (Warburton et al. 1997; Aagaard
et al. 2000).
Epigenetic Determination of Neocentromeres
The cell lines presented here demonstrate at least three
distinct locations for neocentromere formation in chro-
mosome 13q, with multiple independent examples in
chromosome bands 13q32 ( ) and 13q21 ( ) asn = 5 n = 2
well as one example in chromosome band 13q31. The
inversion duplication chromosome from the cell line in
patient 13d, for example, contains a neocentromere in
band 13q32 (ﬁg. 2; ﬁg. 3B). However, although ho-
mologous sequences from 13q32 are also found at the
opposite end of this chromosome as well as on both
copies of the normal chromosome 13 in these cells, only
one of the four homologous regions is forming a neo-
centromere. Thus, the formation of the neocentromere
is indicative of the epigenetic modiﬁcation that is re-
quired ancillary to the primary sequence for centromere
function. The presence of homologous sequences in the
same cell, in both a centromeric state and a noncen-
tromeric state, will permit investigation of the nature of
these epigenetic modiﬁcations.
Despite a requirement for unknown epigenetic mod-
iﬁcation at centromeres, primary DNA sequence may
nonetheless contribute to centromere formation. For ex-
ample, formation of de novo centromeres has been
shown to occur on transfected a-satellite DNA (Har-
rington et al. 1997; Ikeno et al. 1998), albeit at relatively
low frequencies, possibly as the result of an increased
propensity for a-satellite DNA to acquire centromere-
speciﬁc epigenetic modiﬁcations, such as an increased
afﬁnity for CENP-A (Shelby et al. 1997). In this light,
neocentromere sequences may share some sequence
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characteristics with a-satellite DNA that increase their
propensity for centromere formation. Although no con-
served primary-sequence characteristics were observed
in a comparison of a-satellite DNA and the sequenced
80 kb of 10q25.2 neocentromere DNA (Barry et al.
1999), an interesting conserved structural feature con-
sisting of a double-dyad symmetry was observed (Koch
2000). The presence of this or other conserved sequence-
based structures at additional neocentromeres will pro-
vide further evidence for a role for DNA sequence in
centromere formation.
The analysis of multiple neocentromeres in the same
chromosomal location, represented by the 13q32 and
13q21 neocentromere cell lines presented here (table 2),
provides a powerful means with which to address the
importance of primary DNA sequence in neocentromere
formation. If multiple independent neocentromeres from
the same chromosomal location are shown to be forming
on the same underlying genomic clone, this will strongly
suggest a role for that primary DNA sequence in neo-
centromere formation, without the requirement that in-
vestigators recognize conserved sequence characteristics.
The neocentromere DNA from these chromosomes will
be cloned with the use of techniques such as colocali-
zation of physically mapped cosmids and kinetochore
proteins at high resolution on extended chromosome
preparations (du Sart et al. 1997). An alternative ap-
proach is to immunoprecipitate neocentromere-contain-
ing chromatin, with the use of either polyclonal anti-
bodies to endogenous CENP-A or CENP-C, or anti-HA
monoclonal antibodies from neocentromere lines ex-
pressing HA-tagged CENP-A (Vafa and Sullivan 1997).
Positions of Inversion Breakpoints and
Neocentromeres
A reasonable hypothesis would be that neocentrom-
eres might form at the inversion or deletion breakpoints
in chromosomal-rearrangement events, perhaps as a re-
sult of the random acquisition of centromeric epigenetic
modiﬁcations during the disruption of chromatin struc-
ture. However, only 2/40 neocentromeres (15a, 15b; ta-
ble 2) have been reported to occur either at or near
inversion breakpoints, on the basis of cytogenetic char-
acterization, and no neocentromere has been shown to
localize to the inversion breakpoint, when examined
closely with the use of molecular techniques. Further-
more, none of the neocentromeres resulting from inter-
stitial deletion events has occurred at breakpoints. In cell
lines from patients 13a, 13b, 13d, and 13f, cytogenetic
analysis is sufﬁcient to rule out the possibility of neo-
centromere formation at the inversion breakpoint. Nev-
ertheless, in the cell lines of patients 13c, 13e, 13g, and
13h as well as in many of the inversion duplications
from other chromosomes (table 2), it remains a formal
possibility that the neocentromere colocalizes with the
inversion breakpoint. Cell lines from patients 13g and
13h may share a common breakpoint, suggesting a pos-
sible relationship to the neocentromere formation. In
Drosophila, neocentromere formation has been pro-
posed to result from cis-spreading of centromeric epi-
genetic modiﬁcations to neighboring noncentromeric
DNA during chromosome rearrangements (Williams et
al. 1998).
Neocentromere Formation: Selection versus Propensity
The high proportion of neocentromeres on chromo-
some 13q and the lack of neocentromeres on chromo-
somes 18 and 21 suggest that chromosome 13 has a
higher propensity for neocentromere formation that is
distinct from an ascertainment bias for the compatibility
of trisomy 13 with fetal survival. This increased pro-
pensity may be a function of properties such as gene
density, amount of heterochromatin, frequency of chro-
mosomal rearrangements, or even number of endoge-
nous centromeres per unit of DNA length. The possi-
bility remains that chromosome 13q simply contains a
stochastically higher number of primary DNA sequence
motifs that have a high propensity for centromere for-
mation, consistent with the three distinct locations
shown in the present study. Other chromosomal regions
with a high proportion of neocentromere formation in-
clude chromosomes 15q and 3q, for which seven and
ﬁve cases were reported, respectively (table 2).
Despite the possibility for a higher propensity of
neocentromere formation in particular chromosomal
regions, the karyotype of neocentromere-containing cell
lines obtained will nonetheless be constrained by an as-
certainment bias for compatibility with fetal survival
(table 2). Instances of interstitial deletion would have a
positive selection for the neocentromere, to keep the kar-
yotype balanced, which may help to stabilize neocen-
tromere formation. Cases of partial tetrasomy would
have strong negative selection for the neocentromere,
whereas, in cases of partial trisomy, the selection would
depend on whether either monosomy or trisomy for the
duplicated region was more compatible with fetal sur-
vival. Somatic rearrangements involving activation of
neocentromeres would not be subject to selection for
fetal survival and might emerge as mechanisms for neo-
plasia (e.g., Abeliovich et al. 1996).
Thus, we have presented a collection of eight inde-
pendent neocentromeres found in chromosome 13q.
These lines will provide a unique and valuable resource
for investigation of the process of neocentromere for-
mation. Further understanding of neocentromere acti-
vation may suggest strategies to increase the reliability
of providing centromere function to human artiﬁcial
chromosomes.
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Note added in proof.—After acceptance of this man-
uscript, a single example of a chromosome 21–derived
neocentromere has been described on an invdup
21(qterrq21.1::q21.1rneorqter) (Barbi et al. 2000).
This case is unique in that the complementary centric
terminal deletion chromosome 21(pter-q21.1) has not
been recovered, resulting in trisomy 21(q21.1-qter) and
monosomy 21(pter-q21.1).
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